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Abstract
Background: Several studies have highlighted the need for improvement in palliative care delivered to older people
long-term care facilities. However, the available evidence on how to improve palliative care in these settings is weak,
especially in Europe. We describe the protocol of the PACE trial aimed to 1) evaluate the effectiveness and cost-
effectiveness of the ‘PACE Steps to Success’ palliative care intervention for older people in long-term care facilities, and 2)
assess the implementation process and identify facilitators and barriers for implementation in different countries.
Methods: We will conduct a multi-facility cluster randomised controlled trial in Belgium, Finland, Italy, the Netherlands,
Poland, Switzerland and England. In total, 72 facilities will be randomized to receive the ‘Pace Steps to Success
intervention’ or to ‘care as usual’. Primary outcome at resident level: quality of dying (CAD-EOLD); and at staff level:
staff knowledge of palliative care (Palliative Care Survey). Secondary outcomes: resident’s quality of end-of-life care, staff
self-efficacy, self-perceived educational needs, and opinions on palliative care. Economic outcomes: direct costs and
quality-adjusted life years (QALYs).
Measurements are performed at baseline and after the intervention. For the resident-level outcomes, facilities report all
deaths of residents in and outside the facilities over a previous four-month period and structured questionnaires are sent
to (1) the administrator, (2) staff member most involved in care (3) treating general practitioner, and (4) a relative. For the
staff-level outcomes, all staff who are working in the facilities are asked to complete a structured questionnaire. A
process evaluation will run alongside the effectiveness evaluation in the intervention group using the RE-AIM framework.
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Discussion: The lack of high quality trials in palliative care has been recognized throughout the field of palliative care
research. This cross-national cluster RCT designed to evaluate the impact of the palliative care intervention for long-term
care facilities ‘PACE Steps to Success’ in seven countries, will provide important evidence concerning the effectiveness as
well as the preconditions for optimal implementation of palliative care in nursing homes, and this within different health
care systems.
Trial registration: The study is registered at www.isrctn.com – ISRCTN14741671 (FP7-HEALTH-2013-INNOVATION-1
603111) Registration date: July 30, 2015.
Keywords: Nursing home, Care home, Palliative care, End-of-life care, Quality improvement
Background
Aging populations, rising costs and sustainable delivery of
high-quality care are increasingly common concerns all
over Europe [1–3]. While a growing number of older
people will require palliative care in collective institutional
settings, its development has only recently begun in long-
term care facilities [4–7]. Long-term care facilities (in many
countries labelled nursing or care homes) are collective in-
stitutional settings ‘where care – on-site provision of per-
sonal assistance with activities of daily living and on- or
off-site provision of nursing and medical care – is provided
for older people who live there, 24 hours a day, seven days
a week, for an undefined period of time’ [6]. Although resi-
dents of such facilities are not all terminally ill, they can
benefit from a palliative care approach and routine screen-
ing of palliative care needs. Initiatives supporting these fa-
cilities to integrate a palliative care approach may bring
considerable added value to the sector [1, 6]. Several previ-
ous studies have highlighted the need for improvement in
palliative care delivered to older people long-term care fa-
cilities [1, 5, 8].
Nevertheless, the available evidence on how to improve
palliative care in these settings remains weak, particularly
in Europe. A Cochrane review on the effectiveness of
multi-component palliative care interventions in long-term
care facilities show positive results e.g. higher satisfaction
with care and fewer or shorter duration of hospital admis-
sions [9]. Although the results are promising, these studies
had several potential sources of bias and are limited to the
USA [9]. In Europe, there are few studies identified, but all
are small-scale and descriptive, and most were done in the
Netherlands [10]. Currently, available evidence on improv-
ing the quality of palliative care in long-term care facilities,
highlights the importance of a comprehensive approach in
bringing about change [11–13]. Individual targeted inter-
ventions, such as training of care staff, appear ineffective if
not embedded in a broader organizational approach. Rather
than interventions targeting a specific element within a
facility, innovative ‘complex’ palliative care interventions
engaging with facilities and the wider system are needed
[11–13]. Therefore, we carefully developed a complex pal-
liative care intervention ‘PACE Steps to Success’. It aims to
ensure that residents receive high-quality care in long-term
care facilities in Europe through facilitating organisational
change and supporting care staff to develop their roles con-
cerning palliative care. The intervention was based on the
‘Route to Success in Long-term Care Facilities’, a palliative
care intervention developed in the UK [14]. The Route to
Success builds upon the well-known palliative care inter-
vention ‘Gold Standards Framework’ (GSF), which aims to
improve palliative care within primary care and was later
adapted for use in long-term care facilities [15, 16].
Considering the expected future increase of older
people dying in long term care facilities as recent projec-
tion studies have shown [17], there is an urgent need to
increase the evidence base for delivering good palliative
care in these settings. High-quality trials should evaluate
the effectiveness and cost-effectiveness of palliative care,
and measure effects on residents as well as staff. Since
long-term care facilities across Europe vary widely in
terms of type, size, ownership, or health care staff [7], it
will also be important to evaluate how interventions can
be implemented across a variety of different health care
systems. In the PACE randomized controlled cluster trial
(2014–2019), we aim to evaluate the effectiveness and
cost-effectiveness of the ‘PACE Steps to Success’ pallia-
tive care intervention for older people in long-term care
facilities in Europe. It will also assess the implementation
process and identify facilitators and barriers for imple-
mentation across countries and in specific countries.
The aim of this article is to describe the protocol of the
cluster-randomised controlled trial that will be performed
to evaluate the effectiveness, implementation process, and
cost-effectiveness of ‘PACE Steps to Succes’s in long-term
care facilities.
Methods
Trial design
While a classic randomized clinical trial is regarded as
the most appropriate method to study the effect of a
complex intervention, it is impossible to randomise resi-
dents within a long-term care facility without contamin-
ation of the control arm [18]. For this reason, the current
study is designed as a multi-facility cluster randomised
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controlled trial and will use pre- and post-measurement of
relevant outcome variables, process evaluation and eco-
nomic evaluation.
General procedures of the cluster RCT
After inclusion, baseline data are collected in all partici-
pating facilities on 1) deceased residents (ie residents who
died during the previous four months) through after-
death questionnaires sent to four key respondents, 2) on
staff outcomes, and 3) on facility-level characteristics.
Afterwards, each facility is randomised to either the inter-
vention or the control group, which will be done for each
country separately. In the intervention group, ‘PACE Steps
to Success’ will be implemented over a 12-month period.
The control group will continue to provide care as usual.
After the implementation period (month 13), post-
intervention data are collected on deceased residents (ie
residents who died during the previous four months),
staff, and facility. At month 17, post-intervention data on
deceased residents (ie during the previous four months) is
collected for the second time. A process evaluation
will run alongside the outcome evaluation in the interven-
tion group.
The flow diagram of the study is shown in Fig. 1.
Setting
The long-term care facilities are chosen randomly
from a predefined geographical location in Belgium,
the Netherlands, England, Finland, Italy, Poland, and
Switzerland. These facilities have different names across
countries e.g. nursing homes, care homes, homes for the
elderly or residential homes [6].
Inclusion criteria for long-term care facilities are:
 on-site provision of nursing care and personal
assistance with activities of daily living and off-site
family physicians/GPs responsible for the resident’s
medical care;
 Number of beds per care home at least 30;
 15 or more residents died in or outside the nursing
home over the last year (as estimated by the
facilities’ managers);
 Facilties where the Board of Directors expresses
explicit motivation to participate in the study and
agrees to free time for a head nurse or manager to
act as PACE coordinator for approximately 0.5 days
per working week, depending on setting. The Board
are asked to sign a letter of agreement to that effect
to ensure that each LTCF remains motivated to
participate, with a minimum drop-out rate.
Exclusion criteria for long-term care facilities are:
 Facilities already using a palliative care planning tool
e.g. (accredited users of ) the Gold Standards
Framework, Route to Success, Six Steps to Success,
interRAI-PC version or end-of-life care integrated
pathways such as Liverpool Care Pathway;
 Facilities where detailed palliative care guidelines are
available with corresponding high-quality practices
(as judged by the researchers involved in
recruitment);
 Facilties that have been involved in the development
of the intervention materials.
Fig. 1 Flowchart of the cluster randomised controlled trial
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Study population and respondents
The Board of Directors, owner or manager in each partici-
pating facility is asked to assign one contact person for the
study. The assigned contact person identifies all residents
who have died over the previous four-month period and
lists all care staff (nurses and care assistants) employed in
the facility. To collect data on the identified deceased resi-
dents, structured questionnaires including validated in-
struments are sent to four key persons: administrator/
manager, staff member most involved in care (preferably a
nurse), treating general practitioner, and a relative (family
or friend) most closely involved in patient care.
All care staff who are on duty at the time the re-
searcher visits the facility are asked to complete a ques-
tionnaire on knowledge and attitudes towards palliative
care (not linked to a particular deceased resident). For
each participating long-term care facility, a facility ques-
tionnaire will be completed by the administrator/man-
ager to collect data on facility structure, e.g. number of
beds, palliative care provision.
Recruitment of facilities
Researchers contact the facilities by phone or e-mail to
organize a face-to-face meeting, to enquire whether they
would be interested in participating in the study, and to
evaluate inclusion and exclusion criteria. In a first tele-
phone call, the researcher offers to send documentation
introducing the project to the Board of directors/owner/
manager asking for participation (voluntary-based). The
documentation contains an explanation of the interven-
tion, the full research procedure, and an agreement to
participation-form to sign. The face-to-face meeting is
essential to ensure motivation and dedication to partici-
pate with the intervention components and thus prevent
drop out. If a facility declines to participate, another one
fulfilling the inclusion criteria is selected until a suffi-
cient number of facilities (see sample size calculation)
are identified in each country. Facilities declining to par-
ticipate are asked for their reason(s) not to participate.
Randomisation
After consenting to take part in the trial, randomisation
is performed. In each country, half of the facilities are
randomized to the intervention group, where the ‘PACE
Steps to Success’ palliative care intervention is imple-
mented. The other half becomes the control group, where
care continues as usual. Randomization is done by an in-
dependent and blinded statistician from the Netherlands.
More specifically, in each country, the selected long-term
care facilities are first divided into two groups: those with
less than the median number of beds of the selected facil-
ities and those with more than the median number of
beds. Within each group, facilities are subsequently ran-
domized to the intervention or the control group. The
randomization procedure is repeated per country if the
number of beds is unbalanced i.e. if the difference between
the control and intervention groups is greater than 15%.
The randomization procedure will be repeated a max-
imum of two times; if the unbalance persists, the last
randomization result is used for the study.
Intervention
PACE Steps to Success is a standardised palliative care
intervention that aims to integrate basic or general pal-
liative care into the day-to-day routines in long-term
care facilities via a train-the-trainer programme. It is
hypothesised that through the training of facility staff,
staff will provide high-quality palliative care to residents,
which in turn will lead to high quality of dying of resi-
dents. Table 1 shows the six steps of the intervention.
Delivery of the intervention: Train-the-trainer programme
At the core of the intervention is the nomination of a
representative for palliative care within the facility
(named “PACE coordinator”), ensuring that each facility
has a dedicated person who has access to current na-
tional and local information. These coordinators are
supported to develop their knowledge and skills and
then encouraged to empower and train staff within their
organization to deliver palliative care. The coordinators
and staff in the facility are supported by country trainers
who deliver workshops and provide support and educa-
tion to all staff. The country trainers attended a two-day
workshop and a follow-up meeting given by experienced
international trainers (JH and KF) and are supported
during the intervention study monthly by the inter-
national trainers via Google hangout sessions during the
intervention. Trainers are not involved in data collection
for the evaluation of the study. PACE Steps to Success
will be implemented in three phases over a 12-month
period (Fig. 2).
Development and preparation of intervention documents
and materials
The intervention documents and materials (Manager and
facility staff information folder, facility PACE Coordinator
information folder, and a Supporting Tools folder) were
first translated from English into the different country lan-
guages according to the EORTC Quality of Life Group
forward-backward translation procedure [19]. Afterwards,
the intervention documents and materials and the inter-
vention implementation process were reviewed by the
country trainers and by staff in several long-term care fa-
cilities in each country (moderated by the PACE country
trainers, together with the researchers), that did not
participate in the main trial. In a first meeting with the
nursing home management, the process of review was ex-
plained and the proposed method was discussed to ensure
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Table 1 The six steps of the ‘PACE Steps to Success intervention’
Steps Tools/materials Content of the steps
1. Discussions as the end-of-life
approaches
‘Looking and Thinking Ahead’
document
Advance care planning (ACP) discussions with residents and/or
families are conducted to elicit wishes and preferences around
end-of-life care. This communication process usually takes place
in the context of an anticipated deterioration in the individual’s
condition in the future, with attendant loss of capacity to make
decisions and/or ability to communicate wishes to other. ACP
discussions may either be planned or ‘opportunisitic’, meaning
that it can be initiated when a resident brings up the subject
voluntarily. As palliative care aims to improve the quality of the
remaing life, these discussions should not be just about the very
last few days, but also about living well during the last years of life.
2. Assessment, care planning, and
review
‘Mapping Changes in Condition’
chart
Nurses and care assistants are ideally placed to identify the
various clinical triggers that indicate that a frail older person
may be entering the last phase of their life. The ‘Mapping Changes
in Condition’ chart plots deterioration and improvement in a
resident’s physical condition. The chart helps staff recognise
changes over months. By completing this every month (and
every week when a resident is in the last phase of his/her life)
one can see a trajectory over time of how the resident has been.
3. Co-ordination of care Palliative Care Register Monthly
multidisciplinary palliative care
review meetings
Using a Palliative Care Register, residents who are identified as
expected to live less than six months are discussed in detail
during monthly multidisciplinary review meetings. The register
prompts staff about different aspects of care to be considered.
A summary sheet of those residents with particular needs is
completed and sent to health professionals (such as GPs) who
were not able to be present in the meeting.
4. Delivery of high-quality care ‘Long Term Care Facility Pain
Assessment and Management Tool’
‘Geriatric Depression Scale’ (short version)
or ‘Cornell Depression Scale for people
with dementia’
The staff is educated concerning general principles of palliative
care for frail older people including those with dementia,
symptom control and complex communication skills. This step
also involves the training of care staff to assess and manage the
particular symptoms of pain and depression. Pain assessment is
undertaken on all current residents in the facility and on admission
of all new residents. Assessment is continued regularly if pain is
not controlled and/or at a six-monthly review. Assessment of
depression is undertaken if a resident is considered depressed,
or following admission when a resident settled into the nursing
home if mood appears low.
5. Care in the last days of life Integrated care plan for the last days
of life
Use of an integrated care plan for the last days of life to empower
staff to provide high quality care to the dying resident and their
family. The Last Days of Life checklist prompts and guides the
care, ensuring that appropriate medication is available or unnessary
medication is discontinued in anticipation of symptoms during
the dying process.
6. Care after death Monthly reflective de-briefings groups Monthly reflective de-briefings groups to support staff following a
death and encourage experiential learning.
Fig. 2 12-month implementation of PACE Steps to Success
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that it was acceptable. In a second meeting with the man-
agement and at least four staff members – representing all
grades and types of care staff - the ‘PACE Steps to Success’
intervention was explained and the attending staff could
carefully read and comment on the materials and tools. At
a third meeting with the same management and staff, the
intervention materials were reviewed for ease of under-
standing, clarity of process, and potential barriers and fa-
cilitators to use.
Based on the findings of the review, the intervention
documents and materials were adapted to make them
feasible and culturally appropriate for use in long-term
care facilities in the different countries.
Outcome evaluation
Primary outcome
At the level of the resident, the primary outcome is qual-
ity of dying. The primary outcome at the level of the
staff is staff knowledge of palliative care.
Secondary outcomes at staff level
Staff self-efficacy in communicating with residents at the end
of life and their families, staff self-perceived educational
needs regarding patients and family communication and cul-
tural and ethical values, and staff opinions on palliative care.
Secondary outcomes at resident level
Resident’s quality of end-of-life care.
Economic outcomes
Direct costs and quality-adjusted life years (QALYs). Also,
costs per quality increase will be calculated.
Other measures
Relatives’ judgement on quality of end-of-life care and
quality of communication between relatives and physi-
cians, structural facility-level characteristics, clinical and
background characteristics.
The measurement instruments are described in Table 2.
Process evaluation
Alongside the outcome evaluation, we will undertake an em-
bedded process evaluation using the RE-AIM framework.
This framework structures the different implementation fac-
tors that are considered important for implementation effect-
iveness, namely Reach, Efficacy, Adoption, Implementation,
and Maintenance [20]. An overview of the measures used in
the process evaluation can be seen in Table 3.
Sample size calculation
The primary outcome at resident level was used to estimate
the sample size required to detect significant differences
between intervention and control. The power calculation is
aimed at comparing the intervention group with the
control group across all countries, taking the multilevel na-
ture of the data into account. Assuming coefficient of vari-
ation of true means between clusters/countries within each
group of 0.09, group sample sizes of 144 (4 deaths each in
36 LTCFs per study arm across countries) achieve 90%
power to detect a difference of − 3 in quality of dying
(CAD-EOLD scale) and α = .05. CAD-EOLD scores are
based on a comparative Belgian-Dutch study [21].
Taking into account a nonresponse of 20% for staff
and 50% for relatives, we would need to include a mini-
mum of 576 deaths to ensure we can achieve the power
as described above. We estimate that an average number
of 5–6 deaths that can be be identified over a four-month
measurement period per facility of more than 30 beds. A
multi-country database of 72 facilities will be constructed,
for an estimated 432 deaths per four-month period. By
measuring over two such periods, we expect a total of 864
deaths (432 of those with relative responses), leaving
enough room to compensate for lower mortality rates.
Analyses
All data collected through the different questionnaires
will be encoded and stored in Limesurvey. Data cleaning
will be carried out using IBM SPSS syntax operations.
All analyses will be two-tailed with 95% confidence in-
tervals (CIs) and considered significant if α < 0.05.
Outcome and cost evaluation analyses
Anova (normal distribution) or Mann-Whitney U-test
(non-normal distribution) for continuous, and χ2 tests for
categorical variables will be used to describe differences
between the control group and the intervention group in
both the baseline and post-intervention measurements
and for post-hoc non-response analyses. Cluster and study
population characteristics will be reported as mean and
standard deviation (SD) for continuous variables or fre-
quency and percentage for categorical variables.
We will analyse differences for the primary and second-
ary outcomes between the control and the intervention
group using multilevel mixed model analyses that will ac-
count for the baseline measurement and the clustered
study design (i.e. residents and staff nested within a facility
or country). Outcomes will be analyzed with facility and
country as random factor, and group, time point, and their
interaction as fixed factors. We will calculate differ-
ences in mean change (post-intervention measurements
minus baseline) between the intervention group and the
control group (interaction group*time). Results will be
expressed as estimated means with corresponding 95%
CIs. Comparisons will be reported in terms of expected
mean differences with 95% CIs. To interpret the magni-
tude of the effects for the different outcomes, we will esti-
mate effect sizes (Cohen’s d) using the baseline-adjusted
mean differences and the variance between residents,
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between facilities, and between country.(20) The primary
statistical analyses will be by intention-to-treat. All analyses
will be performed using a statistical software that supports
multi-level mixed model analyses – e.g. IBM SPSS Statistics
24: Release 24 (IBM Corporation) or STATA.
Differences in costs and effects will be analyzed by
means of a generalized linear model (GLM), with long
term care facility as cluster. Costs are often right skewed
since there are no negative costs and some patients
incur high costs. Therefore, a gamma distribution will be
Table 2 Overview of measurement instruments
Measurement Unit of analysis Respondent Measurement instruments
Primary outcome
at resident level
Quality of dying of the residents Deceased resident Staff End-of-Life in Dementia Scales – Comfort
Assessment while dying (EOLD-CAD) [23, 24]
Primary outcome
at staff level
Staff knowledge of palliative care Staff Staff Palliative care survey (PCS) construct
‘Palliative care knowledge’ [22]
Secondary
outcomes
Staff self-efficacy (confidence) in
communicating with residents at
the end of life and their families
Staff Staff Self-Efficacy in End-of-Life Care Survey
(S-EOLC) subscale ‘Communication’ [25]
Staff self-perceived educational
needs regarding patient and family
communication and cultural and
ethical values
Staff Staff End-of-Life Professional Caregiver Survey (EPCS),
subscales ‘Patient and family communication’
and ‘cultural and ethical values’ [26]
Staff opinions on palliative care Staff Staff Rotterdam Move2PC, 11 statements
regarding opinions [27]
Quality of end-of-life care Deceased resident Staff Quality of Dying in Long Term Care
(QOD LTC) [28]
Economic
outcomes
Resident’s health-related quality
of life in last week of life in relation
to direct cost of care (intervention
and control)
Deceased resident Staff EuroQol EQ. 5D-5 L (http://www.euroqol.org/)
End-of-Life in Dementia Scales – Comfort
Assessment while dying (EOLD-CAD) [23, 24]
Quality of Dying in Long Term Care
(QOD LTC) [28]
Other measures Quality of end-of-life care according
to the relatives
Deceased resident Relative End-of-Life in Dementia Scales – Satisfaction
with Care (EOLD-SWC) [23, 24]
Quality of communication between
relatives and physicians
Deceased resident Relative Family Perception of Physician-Family
Communication (FPPFC) [29]
Structural, facility level characteristics:
Facility status, type, case-mix, size,
averaged length of stay, staffing and
level of personnel
Facility key person
management
Proposal made by consortium
Palliative care policies of facility Facility key person
management
Based on Belgian survey [8]
Structural quality indicators: Infrastructure,
and access to palliative care
Facility key person
management
EU FP7 IMPACT Structural Quality Indicators
for palliative care [30]
Clinical and background characteristics:
Comorbidities and cause of death Deceased resident Staff
GP
Based on Belgian survey [8]
Functional and cognitive status Deceased resident Staff Bedford Alzheimer Nursing Severity-Scale
BANS-S [31]
Clinical judgements on dementia and
stage of dementia
Deceased resident GP
Staff
Global Deterioration Scale stage 7 (GDS) [32]
Cognitive Performance Scale (CPS) [33]
Age & gender of resident and relative,
relationship to deceased
Deceased resident Key person
management
Relative
Proposal made by consortium
Timing of admission, place of death,
socio-demographics, socio-economic
status, religion/ethnicity
Deceased resident Key person
management
Relative
Proposal made by consortium
Age & gender of staff, experience, level
of education, palliative care training
Staff Staff Proposal made by the consortium
Age & gender of GP, experience,
palliative care training)
Deceased resident GP Proposal made by the consortium
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used. Moreover, a log link will be included as a linear rela-
tion is not assumed. To analyze cost-effectiveness, the net
monetary benefit (NMB) parameter will be calculated.
Then the NMB will be regressed on a set of independent
variables such as group (intervention vs. control), facility
(cluster) and potential confounders such as disease sever-
ity. Means and 95% confidence intervals will be presented.
Finally, the results are presented by means of a cost-
effectiveness acceptability curve (CEAC) that is able to
evaluate the probability being cost-effective by using dif-
ferent WTP thresholds for an extra QALY.
Proces evaluation analysis
Based on key elements of the PACE intervention, criteria
for a high, medium and low level of Reach, Adoption,
Implementation and intention for Maintenance will be
defined. For example, Reach will be rated as ‘high’ if the
mean attendance rate on all six training sessions/meetings
is 70% or higher, ‘medium’ if 30–69% and ‘low’ if below
30%. Using descriptive statistics and other outcomes that
will be gathered with the measurement methods described
in Table 1, we will display how each long-term care facility
within each country performs on the different dimensions.
In addition, we will combine the ratings for Reach, Adop-
tion and Implementation into a combined PACE RAI-
score, which can be linked to the primary and secondary
outcomes of the PACE study; e.g. to analyze whether a
better Reach, Adoption and Implementation of the PACE
Program results in better effect outcomes. The PACE
RAI-score ranges from 0 (if Reach, Adoption and Imple-
mentation are all rated as ‘low’) to 6 (if Reach, Adoption
and Implementation are all rated as ‘high’).
The qualitative data that will be gathered in the online
discussion groups and (group) interviews will be ana-
lyzed according to the principles of thematic analysis, in
a more deductive way (i.e. framework approach). In each
country, two researchers will read and reread the tran-
scripts of the (group) interviews in their native language
to become thoroughly familiar with the data. They will
write extensive summaries including illustrative quotes
Table 3 Operationalization of RE-AIM dimensions measurement methods
Dimension Operationalized in pace process evaluation Measurement methods
Reach
(Proportion of caregivers in care settings that
participated in the intervention during the study)
- Number of participants (care staff attending
each training or meeting) divided by the total
number of care staff (eligible participants) who
work in the facility or facility unit
- Comparing characteristics of participating
facilities with non-participating facilities
- Attendance lists of trainings and meetings
- Documentation of recruitment process
by the researcher
Efficacy
(primary and secondary outcomes (positive
and negative)
- Primary and secondary outcome measures - Questionnaires about deceased resident
- Questionnaire about staff
(see Table 2)
Adoption
(Extent to which caregivers actually adopt the
intervention in the study (followed the intervention
or showed compliance with the intervention)
- Number of Looking and Thinking Ahead
Forms documented and Pain/Depression
Assessments documented
- Experiences with applying the intervention
steps in daily practice (e.g. reasons for (not)
applying steps, changes in practice)
- Report from PACE coordinators
- Group interviews with care staff and PACE
coordinators
Implementation
(Extent to which the intervention is implemented
as intended in the real world, including
implementation barriers and facilitators)
- Fidelity: extent to which the steps of the
intervention were delivered as intended
(frequency, order and content of the sessions)
- Satisfaction of care staff members towards the
intervention program and trainer’s competences
- Barriers and facilitators for implementation
- Structured diaries filled in by country trainers
- Evaluation questionnaire after last training
session filled in by care staff
- List of Barriers and Facilitators for
Implementation, added to the Nurses’
experiences and attitudes questionnaire
- Group interviews with care staff and PACE
coordinators
- Online discussion groups with trainers from
all countries
- Semi-structured interviews with nursing
home managers
- Structured diaries for country trainers and
PACE coordinators
(Intention to) Maintenance
(Extent to which the intervention is intended
to be sustained over time)a
- Care staff members’ intention for using
PACE documents in the future
- Organizational intention for long-term
implementation
- Recommendations for improving usability
of intervention program
- Evaluation questionnaire after last training
session
- Semi-structured interviews with facility
managers
- Group interviews with care staff
- Group interview with PACE coordinators
- Online discussion group with trainers from
all countries
aBecause of the limited duration of the study, we will measure intention for maintenance instead of actual maintenance
Smets et al. BMC Palliative Care  (2018) 17:47 Page 8 of 11
in English, facilitated by templates in which themes are
already pre-structured to some extent. Analysis of the
cross-country data described in these summaries will be
done by two researchers from VUmc, and then discussed
with different members of the research team from all
countries, in order to work towards a consensus about
interpretation of the key findings.
Informed consent
All persons participating in the study (facility managers,
care staff, GPs, relatives, and the concerned residents and
relatives in the interviews for the process evaluation) have
to give their prior informed consent in writing. If residents
are unable to give informed consent, they will not be in-
volved in the study. In some countries, such as Poland
and the Netherlands, a separate informed consent is not
required if questionnaires are filled in anonymously.
Ethics approval
Ethics approval from the relevant ethics committees were
obtained in all participating countries. Belgium: Commissie
Medische Ethiek UZBrussel, 27/05/2015; England:
NHS – NRES Committee North West-Haydock, 10/09/
2015; Finland: Terveyden jahyvinvoinnin laitos, Institutet
för hälsa och välfärd, 30/6/2015; Italy: Comitato Etico, Uni-
versita Cattolica del Sacro Cuore, 6/11/2017; Netherlands:
Medisch Ethische Toetsingscommissie VUMedisch Cen-
trum, 2/7/2015; Poland: Komisja Bioetycza, Uniwersytetu
Jagiellonskiego, 25/6/2015; Switzerland: Commission can-
tonale d’éthique de la recherché scientifique de Genève
(CCER), 6/8/2015.
Discussion
The lack of high quality trials in palliative care has been
recognized throughout the whole field of palliative care
research [1, 5, 10]. This cluster randomized controlled
trial, designed to evaluate the impact of the palliative
care intervention for long-term care facilities ‘PACE
Steps to Success’ in seven countries, is unprecedented
and will provide important evidence concerning the ef-
fectiveness, implementation, and cost-effectiveness of
palliative care for residents of nursing homes.
Unique in the PACE trial is the cross-country set-up
with the participating countries having distinct health
and long-term care systems. The trial’s strengths also in-
clude the focus on outcome and costs, in combination
with an in-depth process evaluation, studying the degree
of implementation of the intervention. The embedded
process evaluation is important in providing evidence on
barriers and facilitators for palliative care implementa-
tion in practice and on relevant contextual factors in
successfully implementing such complex interventions.
It will ensure that the findings of the trial are inform-
ative to practice and policy regardless of whether
evidence is found for an effect on the primary outcomes.
The strengths of the study furthermore lie in its prag-
matic nature, measuring effectiveness of the intervention
in routine nursing home practice, which will enhance
the external validity of the findings. The intervention
materials are available in six languages (English, Dutch,
Finnish, French, Italian, and Polish) and are adapted to
the different cultural contexts, adding further to the ex-
ternal validity of the study.
The intervention used in this study is carefully chosen
and based on the available evidence of what works best
to bring about change in long-term care facilities. When
implementing an innovative and complex intervention
in these facilities it is important to take into account the
facility context, such as leadership, culture, staff capacity
to engage with an innovation, and existing patterns of
working and communicating, as it greatly influences
how long-term care facilities deal with innovations and
their implementation [12]. In the ‘PACE Steps to Suc-
cess’ intervention, we took into account country and
context-specific elements as much as possible during the
intervention development and testing phase, and the
embedded process evaluation using the RE-AIM frame-
work will give insight into the general and country-
specific facilitators and barriers for implementation of
the innovative and complex intervention in long-term
care facilities.
There are also limitations to the study. First, because
the trial is powered across the participating countries,
we will not be able to assess the effectiveness of the
intervention in a particular country. Second, there is un-
certainty whether the Palliative Care Survey instrument
[22] used to measure the primary outcome of the trial
on the staff level, is sensitive enough to detect changes
in staff knowledge over a 1-year time period. Third, we
will do the post-intervention evaluation of the quality of
dying (using the CAD-EOLD instrument [23, 24]) of res-
idents who have died between month 9 and month 17,
while the intervention runs from month 1 tot 12. Hence,
some residents will have died before the intervention is
fully delivered, and others when it has been finalised for
some months already. Thus, it mightbe difficult to truly
capture the effects of the intervention. Forth, due to the
nature of the study design and the intervention, blinding
of treatment allocation is not possible. The nurses and
care assistants who fill in the questionnaires are aware of
and are trained in delivering the intervention, which
might affect their responses on the outcome measures
(i.e. detection or ascertainment bias). However, in view
of the need for evaluations related to the end of life of
the nursing home residents of key persons involved in
care such as nurses and care assistants, we deem their
assessments of the primary outcome at the resident level
an appropriate choice for the study.
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Conclusion
The cross-national cluster RCT of the PACE project will
be the first trial aimed at measuring the effectiveness and
cost-effectiveness of the intervention ‘PACE Steps to Suc-
cess’ to improve palliative care for residents in long-term
care facilities within different health care systems and on a
wide range of outcomes for staff and residents. Combined
with costs and an in-depth process evaluation, this study
will add considerably to the evidence on the implementa-
tion of palliative care for residents of long-term care facil-
ities in different countries. Considering the expected large
increase of elderly people needing institutional care at the
end of life, the ‘PACE Steps to Success’ trial is urgently
needed.
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